Needs of Global Start-up companies (Deliverable 2) GlobalStart wp1 Studies Deliverable 2 Needs of Global Start-up Companies Table of contents p



Download 1.73 Mb.
Page24/31
Date29.07.2017
Size1.73 Mb.
#24297
1   ...   20   21   22   23   24   25   26   27   ...   31

2000-2004


Near future

Business concept

  • Plan

  • Objectives




Provider of genotyping services and genotyping research. Its customers are and will be in clinical and life science academic research.

Approval of the business plan.

Same

Same

Technology platform


Production mode
Market (industry, customer, competitors)

To print and analyze DNA chips.

-No clear customer segmentation.




-The company opens its 3600 sq. feet lab and starts operations.

-Customers: university groups in Western Europe, mainly in France and Germany, and US.




-First products are introduced to the market and consumer agreements were made in 2000.

-In 2004 the company started to offer genotyping service.

-Iso Quality Sertificate (ISO 9001) in 2000.

-A license has been granted to primer extension SNP scoring technology for use in a slide-based array format targeted to the research market in 2002.

-Columbia University buys Genorama – Asper’s product for gene analysis in 2001.

-Private customers in Asia Corea and Taiwan, in 2001, universities in Canada.



The next areas of development for Asper include: DNA diagnostics, pharmacogenomics (studying the link between DNA and variations in human response to therapy) and adding new products to the portfolio of ready-to-use assays.


Finance

  • Source and

  • Use of capital




-Founders' equity in summer 1998.

-Mixture of government grant and loan amounting for 7 million EEK.

-Equity of the management ca. 100 000 EEK.



-Capital investment is carried out from Small Equity Assistance Fund in 2000.

-2million USD from American and Estonian venture capital funds from 1999-2001.

-Minor venture capital funds.

Additional loan of ca 10 million EEK.






People

  • Management,

  • Other employees




-Professor Andres Metspalu.

-5 people, Professor Andres Metspalu, MSc Hendrik Pavel, Dr Neeme Tõnisson and Jana Zernant, MSc from Tartu University, and Dr. Pikani. 2 technicians.

- In 2000, 15 employees.

- In 2001 – 35 employees.

-Currently, 25 persons: 10 researchers, 10 technicians, and 5 administrative personal. When it was established, it employed 5 persons: 3 researchers, and 2 technicians.


-No concrete plans for further hiring.

Partners/ Network

-Tartu University.

-Estonian Bio Center.

-ESTLA, the company involved in Asper´s technology development.



-Potential reseller network established in 2002, for marketing and selling Asper´ s products and services.

- Research institutes, venture capitalists.





3. Internationalization



Know-how/technology

From the beginning Asper could rely on the high-quality expertise on international level from researchers at Tartu University: Professor Metspalu, and Docent Ants Kurg (technological development). As they are among the leading authorities in the field, there was no need for deeper collaboration with other international research centres.


Market

The company could establish their first customer relationships due to Professor Metspalu, and Docent Kurg’s relationship network in Europe and the US.

The company has approximately 60 customers, whereas ca 95% of them are international ones, mainly in the US, but also in Canada, Germany, France, Korea and Taiwan. It has one sales office with one person employed in Munich, Germany. There is a desire to build a reseller network for marketing/selling its products and services. Until today the direct sales mode was applied.
The main client target group is academic institutions, but state owned agencies and private companies are also interested in Asper’s services.
Finance

Since the foundation, the company has received money from venture fund and state’s grant. Asper is satisfied with the money received, however, there are several remarks. Firstly, involvement of venture capital has caused undesirable changes in management and business administration (e.g. supplementary reporting). Secondly, the company counted on venture capitalists’ promise for added-value (consulting on industry structure, markets and competition) in vain.


Staff

The employees are of Estonian nationality.


TTO support

TTO support is limited. When Asper just started in 1998, the company could not get any support from Estonian TTO-s to find customers abroad. It might have also been due to the company’s internal processes, that Asper did not have a transparent marketing and selling plan. At present looking for international customers Asper receives moderate help from Estonian Enterprise (business support agency) and the University.




Quattromed Ltd

Spin-off from the University of Tartu


Download 1.73 Mb.

Share with your friends:
1   ...   20   21   22   23   24   25   26   27   ...   31




The database is protected by copyright ©ininet.org 2024
send message

    Main page